pe
pep-04833 v1 CC-BY-SA-4.0

Blood-pressure-lowering peptide (CVTPALR)

A small natural peptide that blocks ACE, the enzyme that raises blood pressure, helping to lower blood pressure; studied as a potential treatment but not an approved drug.

statusbioassayed targetACE length7 aa refs3
angiotensin-converting-enzyme-ace-inhibitorsanti-hypertensive
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 0 verified on platform
prediction metrics boltz-2 1.0
ipTM0.774
pTM0.667
avg pLDDT90.9
ranking score0.882
STRUCTURE · PEP-04833 × ACE
ranking0.882
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
boltz-2 1.0 · mmCIF ↓ download
sequence7 aa
157
CVTPALR
details expand to inspect
full evidence table2 metrics
metricvaluetool
ipTM 0.7740665674209595 boltz-2
ranking score 0.882023811340332 boltz-2
structural qualityopenfold3
metricvaluenote
gpde0.829global PDE — lower = better
disorderNaNfraction disordered
3-letter notation
Cys-Val-Thr-Pro-Ala-Leu-Arg
recipeboltz-2 1.0
parametervalue
modelboltz-2 1.0
weights
hardwarenvidia_nim_api
mlx version
python
random seed
msa strategynone
diffusion samples1
runtime
predicted bymlx@peptide
predicted at2026-04-24
citationbibtex
peptidemodel (2026). Blood-pressure-lowering peptide (CVTPALR) (pep-04833, v1). PeptideModel. https://peptidemodel.com/card/pep-04833
@peptide{pep04833,
  sequence = {CVTPALR},
  target   = {ace},
  author   = {peptidemodel},
  year     = {2026},
  status   = {bioassayed}
}
related peptides 5 by signal overlap
references 3 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use